BIOGRAPHY

Lisa Eggebrecht

Lisa Eggebrecht is a clinical project manager and medical scientist with several years of professional experience in planning and managing observational studies in various therapeutic areas, e.g. cardiology, and gynecology. Lisa has worked in the fields of health science, systems medicine, and patient-oriented, translational research.

She holds a doctoral degree in Pharmacoepidemiology from the University Medical Center Mainz and a Master´s degree in Toxicology from the Charité in Berlin. During her academic and professional trajectory, she has developed strong competencies in clinical evaluations, data and project management, scientific writing, as well as biostatistics. Lisa has published her work in prestigious peer-reviewed journals and presented at various international conferences. She is experienced in working in multi-disciplinary environments and in leveraging the advantages of cross-cultural teams. Lisa has been a member of ZEG Berlin since 2020.

PUBLICATIONS

2026
Polished but pointless? Assessing the potential of gold and silver-alloy IUDs versus copper-only devices in a large multinational cohort (EURAS- LCS12)  Boehnke Tanja, Lisa Eggebrecht, Rizzo Manuel, Klinghardt Moritz, Klaas Heinemann 2026 Contraception & Reproductive Health Care → DOI
Contraception
2025
Population characteristics of intrauterine device users in real-world clinical practice across Europe – insights from the EURAS-LCS12 study Lisa Eggebrecht, Bauerfeind Anja, Boehnke Tanja, Rizzo Manuel, Hagemann Christine, Jens A. Lange, Viet Mareike, Karl Pauls, von Stockum Sophia, Klinghardt Moritz, Klaas Heinemann 2025 Contraception and Reproductive Medicine. 2025; 10.1186/s40834-025-00353-8. → DOI
Contraception
Real-world use of antispasmodic drugs during IUD insertion – insights from the large observational study EURAS-LCS12 Lisa Eggebrecht, Rizzo Manuel, Klinghardt Moritz, Boehnke Tanja, Clare Barnett, Klaas Heinemann 2025 Contraception & Reproductive Health Care . 2025; 10.1080/13625187.2025.2480086. → DOI
Contraception
Real-world validation of a bleeding prediction algorithm in levonorgestrel intrauterine device users using the MyIUS mobile app Sales Vieira Carolina, Lisa Eggebrecht, Milhoranca Igor Andre, Neumann Robert, Schiffer Acar Mariana, von Stockum Sophia, Frenz Ann-Kathrin 2025 Contraception. 2025; 10.1016/j.contraception.2025.111201. → DOI
Contraception
Use of oral medications prior to IUD insertion – Trends and associations of patient characteristics in a large observational study in Europe (EURAS-LCS12) Klinghardt Moritz, Rizzo Manuel, Boehnke Tanja, Clare Barnett, Klaas Heinemann, Lisa Eggebrecht 2025 Eur J Obstet Gynecol Reprod Biol.. 2025; 10.1016/j.ejogrb.2025.114789. → DOI
Contraception
2024
Does the shape of the copper intrauterine device play a role in expulsion? Results from the ongoing European Active Surveillance Study on LCS12 Boehnke Tanja, Bauerfeind Anja, Lisa Eggebrecht, Cellier Camille, Jens A. Lange, Klaas Heinemann, Madden Tessa 2024 Contraception. 2024; https://doi.org/10.1016/j.contraception.2024.110444. → DOI
Contraception
2023
How did regional lockdowns during the COVID-19 pandemic affect recruitment into a large multinational cohort study of intrauterine device users? Boehnke Tanja, Lisa Eggebrecht, Viet Mareike, Klaas Heinemann, Bauerfeind Anja 2023 Contraception. 2023; 10.1016/j.contraception.2023.110003. → DOI
Contraception

Get in touch

Send a message to the team member.